Literature DB >> 11744811

Downregulation of vascular endothelial growth factor and its receptors in the kidney in rats with puromycin aminonucleoside nephrosis.

Liying Fan1, Tomohiko Wakayama, Shigeru Yokoyama, Osamu Amano, Shoichi Iseki.   

Abstract

AIM: We aimed to examine the possible involvement of vascular endothelial growth factor (VEGF) in the pathogenesis of puromycin aminonucleoside nephrosis (PAN).
METHODS: The expression and localization of the mRNA of VEGF and its receptors, flt-1 and flk-1, were analyzed in the kidneys of puromycin aminonucleoside-injected rats by use of Northern blotting and in situ hybridization.
RESULTS: In association with the induction of proteinuria, VEGF mRNA underwent decrease in amount from 3 days after the injection, reaching the minimum level at 7 days, followed by a gradual recovery by 28 days. The levels of flk-1 and flt-1 mRNA showed similar transient decrease in PAN kidney, whereas the mRNA of von Willebrand factor, a marker of endothelial cells, showed no change in amount. In the normal rat kidney, VEGF mRNA was localized primarily to podocytes, and flk-1 mRNA was localized exclusively to endothelial cells with much higher intensity in glomeruli than in peritubular capillaries. In PAN kidney, the intensities of both VEGF and flk-1 signals in podocytes and glomerular endothelial cells, respectively, appeared much lower at 7 days than in normal kidney.
CONCLUSION: These results indicate that the VEGF-VEGF receptor system is downregulated in PAN, implying that it is not involved in the mechanism of proteinuria in PAN. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11744811     DOI: 10.1159/000046320

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  10 in total

1.  Effects of maternal serum on permeability of glomerular endothelial cell membrane.

Authors:  Hui Du; Haiyi Liu; Jun Zhao; Yuanyuan Wu; Xun Gong; Qiong Zhou; Jingjing Xu; Yuqi Li; Xinwei Shi; Fuyuan Qiao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-02-19

2.  Vascular endothelial growth factor receptor inhibitor enhances dietary salt-induced hypertension in Sprague-Dawley rats.

Authors:  Jian-Wei Gu; R Davis Manning; Emily Young; Megan Shparago; Brandi Sartin; Amelia Purser Bailey
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-05-06       Impact factor: 3.619

3.  Relevance of VEGF and nephrin expression in glomerular diseases.

Authors:  Claudia A Bertuccio
Journal:  J Signal Transduct       Date:  2011-07-26

Review 4.  Therapeutic approach to FSGS in children.

Authors:  Debbie S Gipson; Keisha Gibson; Patrick E Gipson; Sandra Watkins; Marva Moxey-Mims
Journal:  Pediatr Nephrol       Date:  2006-11-16       Impact factor: 3.714

5.  The Accumulation of VEGFA in the Glomerular Basement Membrane and Its Relationship with Podocyte Injury and Proteinuria in Alport Syndrome.

Authors:  Haiyan Wang; Zhihui Yue; Jinlang Wu; Ting Liu; Ying Mo; Xiaoyun Jiang; Liangzhong Sun
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

6.  The Decrement of Hemoglobin Concentration with Angiotensin II Receptor Blocker Treatment Is Correlated with the Reduction of Albuminuria in Non-Diabetic Hypertensive Patients: Post-Hoc Analysis of ESPECIAL Trial.

Authors:  Jung Nam An; Jin Ho Hwang; Jung Pyo Lee; Ho Jun Chin; Sejoong Kim; Dong Ki Kim; Suhnggwon Kim; Jung Hwan Park; Sung Joon Shin; Sang Ho Lee; Bum Soon Choi; Chun Soo Lim
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

7.  Sunitinib induced nephrotic syndrome and thrombotic microangiopathy.

Authors:  P K Jha; M Vankalakunti; V Siddini; R Bonu; G K Prakash; K Babu; H S Ballal
Journal:  Indian J Nephrol       Date:  2013-01

8.  Understanding the mechanisms of proteinuria: therapeutic implications.

Authors:  Jorge E Toblli; P Bevione; F Di Gennaro; L Madalena; G Cao; M Angerosa
Journal:  Int J Nephrol       Date:  2012-07-04

9.  Podocytes regulate neutrophil recruitment by glomerular endothelial cells via IL-6-mediated crosstalk.

Authors:  Sahithi J Kuravi; Helen M McGettrick; Simon C Satchell; Moin A Saleem; Lorraine Harper; Julie M Williams; George Ed Rainger; Caroline O S Savage
Journal:  J Immunol       Date:  2014-05-28       Impact factor: 5.422

10.  Yi qi qing re gao attenuates podocyte injury and inhibits vascular endothelial growth factor overexpression in puromycin aminonucleoside rat model.

Authors:  Yongli Zhan; Liping Yang; Yumin Wen; Huijie Liu; Haojun Zhang; Bin Zhu; Wenbing Han; Yanting Gu; Xueyan Sun; Xi Dong; Tingting Zhao; Huixia Ma; Ping Li
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-21       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.